Skip to main content
. 2000 Feb 29;97(6):2709–2714. doi: 10.1073/pnas.050567397

Figure 3.

Figure 3

The percent of CD3+CD8+ cells of patient 7 that are CD69+IFN-γ+ in response to autologous and heterologous HIVSF162-infected CD4+ T cell targets. Background activity against uninfected CD4+ T cells from each patient is included (left column).